Expression of UBB in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

UBB is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1856.52

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2439.8

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	5099.1
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	4470.1
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	3987.6
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	3962.7
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	3898.9
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	3889.4
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	3863.6
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	3799.3
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	3593.7
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	3535.7
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	3509.6
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	3380.8
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	3338.6
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	3319.6
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	3267.6
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	3247.2
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	3228.0
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	3221.5
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	3220.4
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	3201.1
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	3182.0
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	3160.9
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	3156.4
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	3153.8
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	3146.6
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	3129.6
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	3122.6
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	3099.9
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	3092.6
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	3069.2
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	3062.2
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	3038.7
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	3021.6
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	2997.2
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	2982.4
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	2906.6
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2891.5
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2888.9
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	2888.7
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	2857.4
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	2840.4
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	2835.1
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	2812.3
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2807.3
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	2797.7
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	2785.3
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	2764.7
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	2760.3
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	2752.7
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	2743.1
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	2737.9
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	2734.7
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2708.9
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	2689.4
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	2682.8
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	2681.6
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	2653.9
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	2586.3
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	2578.7
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	2559.4
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	2559.1
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	2540.1
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	2539.2
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	2519.3
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	2496.4
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	2474.2
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	2463.4
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	2438.0
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	2425.7
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	2422.2
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	2407.6
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	2388.6
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	2377.7
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	2365.4
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	2353.7
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	2351.0
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	2346.4
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	2338.5
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	2317.3
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	2293.3
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	2272.9
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	2272.9
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	2269.2
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	2240.9
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	2198.6
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2186.1
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	2181.6
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	2154.7
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	2151.7
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	2140.8
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	2125.0
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	2109.4
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	2096.1
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	2081.6
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	2071.9
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	2056.3
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	2042.5
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	2034.2
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	2024.8
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1974.1
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1958.1
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1921.8
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	1915.6
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1915.1
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1914.2
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	1913.8
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1907.2
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1901.8
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	1890.3
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1887.3
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1883.0
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	1860.2
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	1852.9
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	1807.1
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1790.8
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1790.1
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1774.7
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	1768.4
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1725.1
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	1714.0
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1673.0
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1660.5
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1651.4
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1630.7
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	1611.4
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	1599.3
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	1582.3
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	1567.3
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	1543.4
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1533.2
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	1520.9
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	1409.9
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	1406.8
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1311.8
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1290.5
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1162.0
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1160.4
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	1105.7
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	410.8
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	379.2
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	212.0
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

UBB is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1354.91

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

1575.7

Number of samples

Samples

Sample	Description	pTPM
AK185	N, NA, stage:NA, alive, 330 days	3351.8
AK002	N, NA, stage:NA, dead, 570 days	2884.3
AK134	N, NA, stage:NA, dead, 360 days	2739.4
AK123	N, NA, stage:NA, dead, 180 days	2536.8
AK074	N, NA, stage:NA, alive, 300 days	2492.5
AK051	N, NA, stage:NA, dead, 360 days	2396.3
AK165	N, NA, stage:NA, alive, 360 days	2292.0
AK142	N, NA, stage:NA, alive, 90 days	2253.3
AK139	N, NA, stage:NA, dead, 270 days	2229.7
AK158	N, NA, stage:NA, dead, 360 days	1998.4
AK156	N, NA, stage:NA, dead, 330 days	1953.6
AK071	N, NA, stage:NA, dead, 540 days	1933.3
AK173	N, NA, stage:NA, dead, 180 days	1920.7
AK098	N, NA, stage:NA, dead, 660 days	1911.6
AK149	N, NA, stage:NA, dead, 420 days	1908.5
AK088	N, NA, stage:NA, dead, 360 days	1907.1
AK178	N, NA, stage:NA, dead, 240 days	1897.0
AK043	N, NA, stage:NA, alive, 660 days	1896.6
AK188	N, NA, stage:NA, alive, 420 days	1867.3
AK072	N, NA, stage:NA, dead, 150 days	1809.6
AK226	N, NA, stage:NA, dead, 360 days	1784.6
AK183	N, NA, stage:NA, alive, 360 days	1778.7
AK006	N, NA, stage:NA, dead, 360 days	1769.5
AK167	N, NA, stage:NA, dead, 180 days	1760.0
AK216	N, NA, stage:NA, dead, 360 days	1758.6
AK100	N, NA, stage:NA, alive, 960 days	1711.0
AK015	N, NA, stage:NA, alive, 720 days	1691.3
AK003	N, NA, stage:NA, dead, 600 days	1665.3
AK079	N, NA, stage:NA, dead, 210 days	1617.6
AK236	N, NA, stage:NA, dead, 360 days	1614.9
AK055	N, NA, stage:NA, dead, 240 days	1584.2
AK035	N, NA, stage:NA, dead, 210 days	1520.6
AK117	N, NA, stage:NA, dead, 210 days	1507.3
AK227	N, NA, stage:NA, alive, 300 days	1482.9
AK081	N, NA, stage:NA, dead, 180 days	1448.9
AK099	N, NA, stage:NA, dead, 420 days	1423.1
AK068	N, NA, stage:NA, alive, 360 days	1421.1
AK218	N, NA, stage:NA, dead, 180 days	1398.3
AK091	N, NA, stage:NA, dead, 210 days	1369.9
AK030	N, NA, stage:NA, dead, 120 days	1360.5
AK085	N, NA, stage:NA, alive, 660 days	1349.4
AK076	N, NA, stage:NA, alive, 660 days	1298.5
AK089	N, NA, stage:NA, dead, 330 days	1296.1
AK053	N, NA, stage:NA, dead, 300 days	1285.6
AK133	N, NA, stage:NA, dead, 360 days	1224.2
AK199	N, NA, stage:NA, alive, 1860 days	1173.8
AK005	N, NA, stage:NA, dead, 240 days	1093.0
AK049	N, NA, stage:NA, dead, 180 days	1086.7
AK153	N, NA, stage:NA, dead, 240 days	976.1
AK041	N, NA, stage:NA, alive, 810 days	920.1
AK195	N, NA, stage:NA, dead, 390 days	805.0
AK205	N, NA, stage:NA, dead, 120 days	801.2
AK103	N, NA, stage:NA, alive, 1320 days	753.6
AK231	N, NA, stage:NA, dead, 240 days	502.1
AK124	N, NA, stage:NA, alive, 1920 days	450.3
AK066	N, NA, stage:NA, alive, 960 days	265.6
AK102	N, NA, stage:NA, alive, 1740 days	141.9
AK213	N, NA, stage:NA, alive, 2010 days	123.8
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0206330003	Tumor	N/A
CPT0186100003	Tumor	N/A
CPT0123530003	Tumor	N/A
CPT0201710003	Tumor	N/A
CPT0216920008	Tumor	N/A
CPT0218890004	Tumor	N/A
CPT0224390004	Tumor	N/A
CPT0204390003	Normal	N/A
CPT0093590003	Tumor	N/A
CPT0167750004	Tumor	N/A
CPT0204400003	Normal	N/A
CPT0079790003	Tumor	N/A
CPT0218690004	Tumor	N/A
CPT0204370003	Normal	N/A
CPT0161730003	Tumor	N/A
CPT0168720003	Tumor	N/A
CPT0206880003	Tumor	N/A
CPT0189650004	Tumor	N/A
CPT0204350003	Normal	N/A
CPT0168380003	Tumor	N/A
CPT0205890003	Tumor	N/A
CPT0217880003	Tumor	N/A
CPT0206560003	Tumor	N/A
CPT0087680003	Tumor	N/A
CPT0206000004	Tumor	N/A
CPT0218670003	Tumor	N/A
CPT0204340003	Normal	N/A
CPT0189850004	Tumor	N/A
CPT0224330003	Tumor	N/A
CPT0218330004	Tumor	N/A
CPT0167640003	Tumor	N/A
CPT0002410011	Tumor	N/A
CPT0093450003	Tumor	N/A
CPT0206110003	Tumor	N/A
CPT0217430008	Tumor	N/A
CPT0217000004	Tumor	N/A
CPT0196850003	Tumor	N/A
CPT0189250003	Tumor	N/A
CPT0189570004	Tumor	N/A
CPT0162020003	Tumor	N/A
CPT0167530003	Tumor	N/A
CPT0207030003	Tumor	N/A
CPT0127420003	Tumor	N/A
CPT0205670004	Tumor	N/A
CPT0208980003	Tumor	N/A
CPT0206780003	Tumor	N/A
CPT0182500003	Tumor	N/A
CPT0217710008	Tumor	N/A
CPT0168830003	Tumor	N/A
CPT0182550003	Tumor	N/A
CPT0189460003	Tumor	N/A
CPT0167860004	Tumor	N/A
CPT0125220003	Tumor	N/A
CPT0171580008	Tumor	N/A
CPT0087730003	Tumor	N/A
CPT0104330003	Tumor	N/A
CPT0168590003	Tumor	N/A
CPT0205450004	Tumor	N/A
CPT0219080004	Tumor	N/A
CPT0087570003	Tumor	N/A
CPT0162140003	Tumor	N/A
CPT0175060003	Tumor	N/A
CPT0205780003	Tumor	N/A
CPT0218960004	Tumor	N/A
CPT0064650003	Tumor	N/A
CPT0125570003	Tumor	N/A
CPT0190360004	Tumor	N/A
CPT0206670004	Tumor	N/A
CPT0204380003	Normal	N/A
CPT0092440003	Tumor	N/A
CPT0162100003	Tumor	N/A
CPT0221180003	Tumor	N/A
CPT0225760003	Tumor	N/A
CPT0093510003	Tumor	N/A
CPT0190240004	Tumor	N/A
CPT0228220003	Tumor	N/A
CPT0204410003	Normal	N/A
CPT0224540004	Tumor	N/A
CPT0209440003	Tumor	N/A
CPT0089150003	Tumor	N/A
CPT0204360003	Normal	N/A
CPT0168080003	Tumor	N/A
CPT0078580003	Tumor	N/A
CPT0127480003	Tumor	N/A
CPT0204420003	Normal	N/A
CPT0218830004	Tumor	N/A
CPT0225730003	Tumor	N/A
CPT0093360003	Tumor	N/A
CPT0168270003	Tumor	N/A
CPT0206450003	Tumor	N/A
CPT0207090003	Tumor	N/A
CPT0104220003	Tumor	N/A
CPT0224600003	Tumor	N/A
CPT0087950003	Tumor	N/A
CPT0204330003	Normal	N/A
CPT0199770003	Tumor	N/A
CPT0205570003	Tumor	N/A
CPT0093550003	Tumor	N/A
CPT0167970003	Tumor	N/A
CPT0182580003	Tumor	N/A
CPT0168480003	Tumor	N/A
CPT0206230003	Tumor	N/A
CPT0189750004	Tumor	N/A
CPT0217100003	Tumor	N/A
CPT0064890003	Tumor	N/A
CPT0217190003	Tumor	N/A
CPT0218770003	Tumor	N/A
CPT0125510003	Tumor	N/A
CPT0217060003	Tumor	N/A
CPT0071100003	Tumor	N/A
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA041344	Antibody HPA049132	Antibody CAB013048
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, Low grade
Glioma, malignant, High grade